You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

camrelizumab(shr-1210)

Showing 1 - 2 of 2
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma Trial in Beijing (Camrelizumab(SHR-1210))

Unknown status
  • Hodgkin Lymphoma
  • Camrelizumab(SHR-1210)
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 22, 2020

Acute Myeloid Leukemia Trial (Camrelizumab(SHR-1210), Decitabine)

Unknown status
  • Acute Myeloid Leukemia
  • (no location specified)
Apr 16, 2020